|
|
|
Volumn 4, Issue 6, 2008, Pages 758-
|
|
EUTOS for chronic myeloid leukemia shows improved management and dose optimization is required.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
IMATINIB;
PIPERAZINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
BLOOD;
CHRONIC MYELOID LEUKEMIA;
HOSPITAL LABORATORY;
HUMAN;
NOTE;
REGISTER;
STANDARD;
ANTINEOPLASTIC AGENTS;
HUMANS;
LABORATORIES, HOSPITAL;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
PIPERAZINES;
PYRIMIDINES;
REGISTRIES;
|
|
EID: 61449430444
PISSN: None
EISSN: 17448301
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|